PPA
IRWD icon

Parametric Portfolio Associates’s Ironwood Pharmaceuticals IRWD Stock Holding History

Parametric Portfolio Associates’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$6.72M Sell
534,384
-10,385
-2% -$119K ﹤0.01% 1647
2021
Q4 		$6.35M Buy
544,769
+81,614
+18% +$1M ﹤0.01% 1690
2021
Q3 		$6.05M Buy
463,155
+89,669
+24% +$1.16M ﹤0.01% 1704
2021
Q2 		$4.81M Buy
373,486
+191,055
+105% +$2.19M ﹤0.01% 1875
2021
Q1 		$2.04M Sell
182,431
-47,035
-20% -$497K ﹤0.01% 2764
2020
Q4 		$2.61M Buy
229,466
+31,878
+16% +$349K ﹤0.01% 2487
2020
Q3 		$1.78M Buy
197,588
+43,579
+28% +$433K ﹤0.01% 2579
2020
Q2 		$1.59M Buy
154,009
+27,584
+22% +$282K ﹤0.01% 2647
2020
Q1 		$1.28M Sell
126,425
-70,773
-36% -$832K ﹤0.01% 2659
2019
Q4 		$2.63M Buy
197,198
+116,112
+143% +$1.28M ﹤0.01% 2514
2019
Q3 		$696K Buy
81,086
+18,478
+30% +$180K ﹤0.01% 3212
2019
Q2 		$685K Buy
62,608
+216
+0.3% +$2.42K ﹤0.01% 3235
2019
Q1 		$707K Buy
62,392
+4,022
+7% +$44.9K ﹤0.01% 3193
2018
Q4 		$506K Sell
58,370
-32,120
-35% -$369K ﹤0.01% 3308
2018
Q3 		$1.4M Sell
90,490
-7,953
-8% -$126K ﹤0.01% 2921
2018
Q2 		$1.58M Buy
98,443
+14,365
+17% +$213K ﹤0.01% 2824
2018
Q1 		$1.09M Sell
84,078
-7,785
-8% -$97K ﹤0.01% 2971
2017
Q4 		$1.15M Buy
91,863
+14,337
+18% +$187K ﹤0.01% 2946
2017
Q3 		$1.02M Buy
77,526
+966
+1% +$13.3K ﹤0.01% 3029
2017
Q2 		$1.21M Sell
76,560
-19,787
-21% -$288K ﹤0.01% 2865
2017
Q1 		$1.38M Buy
96,347
+3,478
+4% +$47.6K ﹤0.01% 2692
2016
Q4 		$1.19M Buy
92,869
+20,768
+29% +$262K ﹤0.01% 2726
2016
Q3 		$959K Sell
72,101
-11
-0% -$129 ﹤0.01% 2836
2016
Q2 		$790K Buy
72,112
+7,332
+11% +$71.6K ﹤0.01% 2976
2016
Q1 		$594K Buy
64,780
+13,155
+25% +$109K ﹤0.01% 3237
2015
Q4 		$501K Sell
51,625
-13,432
-21% -$130K ﹤0.01% 3249
2015
Q3 		$568K Sell
65,057
-10,918
-14% -$102K ﹤0.01% 2658
2015
Q2 		$767K Sell
75,975
-18,616
-20% -$216K ﹤0.01% 2982
2015
Q1 		$1.27M Buy
94,591
+9,844
+12% +$129K ﹤0.01% 2607
2014
Q4 		$1.09M Buy
84,747
+25,757
+44% +$295K ﹤0.01% 2711
2014
Q3 		$640K Sell
58,990
-2,715
-4% -$31.1K ﹤0.01% 3043
2014
Q2 		$792K Buy
61,705
+32,216
+109% +$350K ﹤0.01% 2894
2014
Q1 		$304K Buy
29,489
+8,586
+41% +$96.5K ﹤0.01% 3443
2013
Q4 		$203K Buy
20,903
+5,555
+36% +$49.9K ﹤0.01% 3617
2013
Q3 		$152K Buy
15,348
+2,950
+24% +$28.9K ﹤0.01% 3666
2013
Q2 		$103K Buy
+12,398
New +$150K ﹤0.01% 3592

Other funds holding IRWD

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Parametric Portfolio Associates's IRWD Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Ironwood Pharmaceuticals (IRWD) stake by 1.9% in Q1 2022, selling an estimated $119K and leaving 534,384 shares worth $6.72M. The position accounts for ﹤0.01% of the portfolio, ranked #1647.

Parametric Portfolio Associates first reported a position in IRWD in Q2 2013 and has held it in 36 quarters since. 221 funds tracked by Wall St. Rank hold IRWD as of Q1 2022.

  • Parametric Portfolio Associates held 534,384 shares of Ironwood Pharmaceuticals worth $6.72M as of Q1 2022.
  • Parametric Portfolio Associates sold 10,385 Ironwood Pharmaceuticals shares in Q1 2022, an estimated $119K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #1647 holding.
  • Parametric Portfolio Associates first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 36 quarters since.
  • 221 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.